Format
Items per page
Sort by

Send to:

Choose Destination

Links from Protein

Items: 1 to 20 of 101

1.

Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome.

Meester JA, Southgate L, Stittrich AB, Venselaar H, Beekmans SJ, den Hollander N, Bijlsma EK, Helderman-van den Enden A, Verheij JB, Glusman G, Roach JC, Lehman A, Patel MS, de Vries BB, Ruivenkamp C, Itin P, Prescott K, Clarke S, Trembath R, Zenker M, Sukalo M, Van Laer L, Loeys B, Wuyts W.

Am J Hum Genet. 2015 Sep 3;97(3):475-82. doi: 10.1016/j.ajhg.2015.07.015. Epub 2015 Aug 20.

PMID:
26299364
2.

Maturation-associated Dbf4 expression is essential for mouse zygotic DNA replication.

Murai S, Katagiri Y, Yamashita S.

Dev Growth Differ. 2014 Dec;56(9):625-39. doi: 10.1111/dgd.12180. Epub 2014 Oct 27.

PMID:
25348865
3.

Aberrant expression of δ-like ligand 4 contributes significantly to axillary lymph node metastasis and predicts postoperative outcome in breast cancer.

Xiao M, Yang S, Ning X, Huang Y.

Hum Pathol. 2014 Nov;45(11):2302-10. doi: 10.1016/j.humpath.2014.04.025. Epub 2014 Aug 13.

PMID:
25260720
4.

Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.

Hu GH, Liu H, Lai P, Guo ZF, Xu L, Yao XD, Zheng JH, Liu M, Xu YF.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2143-52. eCollection 2014.

5.

Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.

Huang QB, Ma X, Li HZ, Ai Q, Liu SW, Zhang Y, Gao Y, Fan Y, Ni D, Wang BJ, Zhang X.

Oncotarget. 2014 May 30;5(10):3066-75.

6.

Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis.

Kontomanolis E, Panteliadou M, Giatromanolaki A, Pouliliou S, Efremidou E, Limberis V, Galazios G, Sivridis E, Koukourakis MI.

Med Oncol. 2014 May;31(5):945. doi: 10.1007/s12032-014-0945-0. Epub 2014 Apr 3.

PMID:
24696220
7.

Dll4-containing exosomes induce capillary sprout retraction in a 3D microenvironment.

Sharghi-Namini S, Tan E, Ong LL, Ge R, Asada HH.

Sci Rep. 2014 Feb 7;4:4031. doi: 10.1038/srep04031.

8.

Expression of Notch signaling components in cutaneous foreign body and sarcoidal granulomas and fusing macrophages.

Rangel JR, Chung Y, Rosenbach M, Ziober AF, Zhang PJ, Schaffer A.

Am J Dermatopathol. 2014 May;36(5):409-13. doi: 10.1097/DAD.0b013e3182a730cb.

9.

Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases.

Fukuda D, Aikawa M.

Circ J. 2013;77(10):2462-8. Epub 2013 Sep 12. Review.

10.

Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.

Li GG, Li L, Li C, Ye LY, Li XW, Liu DR, Bao Q, Zheng YX, Xiang DP, Chen L, Chen J.

World J Gastroenterol. 2013 Jul 28;19(28):4486-94. doi: 10.3748/wjg.v19.i28.4486.

11.

Clinical implications of DLL4 expression in gastric cancer.

Ishigami S, Arigami T, Uenosono Y, Okumura H, Kurahara H, Uchikado Y, Setoyama T, Kita Y, Kijima Y, Nishizono Y, Nakajo A, Owaki T, Ueno S, Natsugoe S.

J Exp Clin Cancer Res. 2013 Jul 30;32:46. doi: 10.1186/1756-9966-32-46.

12.

Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma.

Zhang JX, Cai MB, Wang XP, Duan LP, Shao Q, Tong ZT, Liao DZ, Li YY, Huang MY, Zeng YX, Shao JY.

Med Oncol. 2013 Mar;30(1):390. doi: 10.1007/s12032-012-0390-x. Epub 2012 Dec 30.

PMID:
23275120
13.

Delta-like ligand 4 correlates with endothelial proliferation and vessel maturation in human malignant glioma.

Li ZQ, Gong LL, Wen ZH, Wang J, Xu CS, Huang XD.

Onkologie. 2012;35(12):763-8. doi: 10.1159/000345116. Epub 2012 Nov 20.

PMID:
23207622
14.

High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).

Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL.

Angiogenesis. 2013 Apr;16(2):343-51. doi: 10.1007/s10456-012-9318-5. Epub 2012 Oct 30.

PMID:
23108591
15.

Delta-like ligand 4-notch blockade and tumor radiation response.

Liu SK, Bham SA, Fokas E, Beech J, Im J, Cho S, Harris AL, Muschel RJ.

J Natl Cancer Inst. 2011 Dec 7;103(23):1778-98. doi: 10.1093/jnci/djr419. Epub 2011 Oct 18.

16.
17.

Feed-forward signaling by membrane-bound ligand receptor circuit: the case of NOTCH DELTA-like 4 ligand in endothelial cells.

Caolo V, van den Akker NM, Verbruggen S, Donners MM, Swennen G, Schulten H, Waltenberger J, Post MJ, Molin DG.

J Biol Chem. 2010 Dec 24;285(52):40681-9. doi: 10.1074/jbc.M110.176065. Epub 2010 Oct 19.

18.

New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes.

Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, Oon CE, Leek R, Edelmann M, Kessler B, Sainson RC, Sargent I, Li JL, Harris AL.

Blood. 2010 Sep 30;116(13):2385-94. doi: 10.1182/blood-2009-08-239228. Epub 2010 Jun 17.

19.

Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.

Al Haj Zen A, Oikawa A, Bazan-Peregrino M, Meloni M, Emanueli C, Madeddu P.

Circ Res. 2010 Jul 23;107(2):283-93. doi: 10.1161/CIRCRESAHA.110.221663. Epub 2010 May 27.

20.

Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer.

Oishi H, Sunamura M, Egawa S, Motoi F, Unno M, Furukawa T, Habib NA, Yagita H.

Pancreas. 2010 Aug;39(6):897-903. doi: 10.1097/MPA.0b013e3181ce7185.

PMID:
20182391
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk